Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

GKOS

GLAUKOS Corp

Healthcare · Surgical & Medical Instruments & Apparatus

$154.43Sep 25, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

GLAUKOS Corp shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +50% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +50% YoY in Q2 FY2026

Pipeline evidence · 23d ago

GKOS's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on GKOS.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full GKOS earnings analysis

Reported figures for GLAUKOS Corp — research only, not investment advice.

Revenue YoY
+49.5%

Latest Intelligence

Updated

What happened recently for GLAUKOS Corp (GKOS) — events, not interpretation.

Event
Reported Q2 2026 revenue +50% YoY.
Also
Last session September 25, 2026 at $154.43.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

GLAUKOS Corp (GKOS)

Healthcare · Surgical & Medical Instruments & Apparatus

Investment Snapshot above is the primary AlphaOS analysis for GLAUKOS Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$9.11B
Revenue:
$507.44M

GKOS earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow GLAUKOS Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.

Structured stock intelligence for companies connected to this research.